Matthew Gline, CEO: Roivant Sciences ROIV Sell · Filed 24/09/24

Trade details

Type: Insider sale
Amount: $23,382,600.03
Shares · price: 1,983,257 sh · $11.79 a share
Held after: 17,870,543 sh
Stock: Roivant Sciences ROIV
Person: Matthew GlineCEO
Trade date: 24/09/23
Filed: 24/09/24
Days to filing: 1 days

Sold 10.0% of holdings

Share of holding sold: 10.0%

Roivant Sciences trades, last 26 weeks

What else happened in Roivant Sciences around then

Filed or reported within 30 days of the trade day · 24/08/24~24/10/23

Matthew Gline's recent trades

Matthew GlineCEO
SellRoivant Sciences
Sell
Roivant Sciences
ROIV
$8.4M
289,774 sh
$8.4M
Filed 04/20
Traded 04/16
Matthew GlineCEO
Planned saleRoivant Sciences
Planned sale
Roivant Sciences
ROIV
$8.4M
289,774 sh
$8.4M
Filed 04/16
Traded 04/16
Matthew GlineCEO
SellRoivant Sciences
Sell
Roivant Sciences
ROIV
$20.5M
943,527 sh
$20.5M
Filed 25/12/17
Traded 25/12/15
Matthew GlineCEO
SellRoivant Sciences
Sell
Roivant Sciences
ROIV
$12.3M
566,116 sh
$12.3M
Filed 25/12/17
Traded 25/12/15
Matthew GlineCEO
SellRoivant Sciences
Sell
Roivant Sciences
ROIV
$5M
230,357 sh
$5M
Filed 25/12/17
Traded 25/12/15